Financial News
All News about Harmony Biosciences Holdings Inc
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
A Look Into Healthcare Sector Value Stocks
August 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/14/zynerba_pharmaceuticals_zyne_stock_.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/valuestocks_1600_04.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Harmony Biosciences
August 01, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://ml.globenewswire.com/media/8742b343-2edb-40bd-a6d6-2fd4a3d1c7db/small/harmony-logo-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Harmony Biosciences's Earnings Outlook
July 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Harmony Biosciences's Future
June 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_03.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_3353.jpeg?width=1200&height=800&fit=crop)
Earnings Outlook For Harmony Biosciences
May 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Harmony Biosciences
April 17, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://ml.globenewswire.com/media/8742b343-2edb-40bd-a6d6-2fd4a3d1c7db/small/harmony-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/nvax-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20230330005741/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230329005888/en/538768/22/BES_Mark.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.